Over 10 years experience of Traceability Solutions
By pharmatrax
Category: News
No CommentsInfectious disease experts weigh in on playdates, playgrounds and other parenting questions To slow the spread of the coronavirus, society is becoming much less social.…
By pharmatrax
Category: News
No CommentsResearchers in the US have mapped a SARS-CoV-2 protein, which could help use drugs developed to treat SARS coronavirus as effective treatments for the new…
By pharmatrax
Category: News
No CommentsIt urges regulator to recall popular drug; FDA says its tests show levels of NDMA acceptable NEW YORK • High levels of the probable carcinogen…
By pharmatrax
Category: News
No CommentsThousands of medicinal samples to be tested in Belgium for inhibiting impact on virus Bill and Melinda Gates have paid for 15,000 medicinal molecules to be shipped…
By pharmatrax
Category: Technoloy
No CommentsThe work is being highlighted at this week’s AAAI-20 Conference in New York City IBM this week unveiled new research on how an artificial intelligence (AI) model…
By pharmatrax
Category: News
No CommentsThe halal pharmaceuticals market research report assesses the market demand, trends, and opportunities for the period 2018 to 2025. The report highlights the historic trends…
By pharmatrax
Category: News
No CommentsThe British Heart Foundation’s “Big Beat Challenge” has revealed its four finalists, which will now compete to win a £30 million funding award. The organization…
By pharmatrax
Category: Technoloy
No Comments“I want to build a business that profiles every single researcher and healthcare professionals in the world and I want to sell it to industry,”…
By pharmatrax
Category: Technoloy
No CommentsDrug Target Review explores the latest applications of stem cells in modeling disease, drug production and the most recent steps in regenerative medicine provided by…
By pharmatrax
Category: News
No CommentsYou’re unwell, you see a doctor, they prescribe you a medicine… and you take it. But how exactly is that drug having an effect? What is its…